Oscotec and ADEL License Alzheimer’s Drug Candidate to Sanofi in KRW 1.5 Trillion Deal
Oscotec Inc. announced on the 16th that it has licensed an Alzheimer’s disease drug candidate jointly researched and…
ADEL
1 개의 기사가 있습니다.